$2.47T
Total marketcap
$66.3B
Total volume
BTC 50.32%     ETH 15.99%
Dominance

ResMed Inc. 0KW4.L Stock

184.59 USD {{ price }} -3.056566% {{change_pct}}%
Exchange
LSE
Market Cap
259.63M USD
LOW - HIGH [24H]
0.0000 - 0.0000 USD
VOLUME [24H]
320 USD
{{ volume }}
P/E Ratio
0.34
Earnings per share
5.3 USD

ResMed Inc. Price Chart

ResMed Inc. 0KW4.L Financial and Trading Overview

ResMed Inc. stock price 184.59 USD
Previous Close 218.7 USD
Open 0 USD
Bid 0 USD x 0
Ask 0 USD x 0
Day's Range 0 - 0 USD
52 Week Range 0 - 246.69 USD
Volume 2.28K USD
Avg. Volume 2.15K USD
Market Cap 304.72M USD
Beta (5Y Monthly) 0.480633
PE Ratio (TTM) 0.40885395
EPS (TTM) 5.3 USD
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est N/A

0KW4.L Valuation Measures

Enterprise Value 33.62B USD
Trailing P/E 0.40885395
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 0.0758839
Price/Book (mrq) 8.094288
Enterprise Value/Revenue 8.372
Enterprise Value/EBITDA 26.817

Trading Information

ResMed Inc. Stock Price History

Beta (5Y Monthly) 0.480633
52-Week Change 9.44%
S&P500 52-Week Change 20.43%
52 Week High 246.69 USD
52 Week Low 0 USD
50-Day Moving Average 223.52 USD
200-Day Moving Average 221.71 USD

0KW4.L Share Statistics

Avg. Volume (3 month) 2.15K USD
Avg. Daily Volume (10-Days) 119 USD
Shares Outstanding 142.5M
Float 145.57M
Short Ratio N/A
% Held by Insiders 1.29%
% Held by Institutions 66.45%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 1.74
Trailing Annual Dividend Yield 0.79%
5 Year Average Dividend Yield N/A
Payout Ratio N/A
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends June 30, 2022
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End June 30, 2023

Profitability

Profit Margin 21.49%
Operating Margin (ttm) 27.92%
Gross Margin 57.00%
EBITDA Margin 31.21%

Management Effectiveness

Return on Assets (ttm) 12.06%
Return on Equity (ttm) 23.93%

Income Statement

Revenue (ttm) 4.02B USD
Revenue Per Share (ttm) 27.39 USD
Quarterly Revenue Growth (yoy) 29.19%
Gross Profit (ttm) 2.06B USD
EBITDA 1.25B USD
Net Income Avi to Common (ttm) 862.95M USD
Diluted EPS (ttm) 5.299
Quarterly Earnings Growth (yoy) 29.89%

Balance Sheet

Total Cash (mrq) 240.01M USD
Total Cash Per Share (mrq) 1.63 USD
Total Debt (mrq) 1.72B USD
Total Debt/Equity (mrq) 43.84 USD
Current Ratio (mrq) 3.069
Book Value Per Share (mrq) 26.766

Cash Flow Statement

Operating Cash Flow (ttm) 535.35M USD
Levered Free Cash Flow (ttm) 288.28M USD

Profile of ResMed Inc.

Country United Kingdom
State CA
City San Diego
Address 9001 Spectrum Center Boulevard
ZIP 92123
Phone 858 836 5000
Website https://www.resmed.com
Industry
Sector(s)
Full Time Employees 8160

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME)to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; and HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies. The company markets its products primarily to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force in approximately 140 countries. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.

Q&A For ResMed Inc. Stock

What is a current 0KW4.L stock price?

ResMed Inc. 0KW4.L stock price today per share is 184.59 USD.

How to purchase ResMed Inc. stock?

You can buy 0KW4.L shares on the LSE exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for ResMed Inc.?

The stock symbol or ticker of ResMed Inc. is 0KW4.L.

How many shares does ResMed Inc. have in circulation?

The max supply of ResMed Inc. shares is 1.41M.

What is ResMed Inc. Price to Earnings Ratio (PE Ratio)?

ResMed Inc. PE Ratio is 0.34834874 now.

What was ResMed Inc. earnings per share over the trailing 12 months (TTM)?

ResMed Inc. EPS is 5.3 USD over the trailing 12 months.